
French artificial intelligence (AI) software developer Avicenna.AI has partnered with German radiology AI platform provider Deepc on AI algorithms for brain imaging.
As a result, Avicenna's stroke suite of triage and quantification algorithms will be available on Deepc's deepcOS platform. Two Avicenna triage applications -- CINA-LVO for flagging suspected large vessel occlusion (LVO) on CT angiography and CINA-ICH for highlighting suspected acute intracranial hemorrhage (ICH) on CT scans -- have received U.S. Food and Drug Administration clearance.
A third tool -- CINA-ASPECTS for automatically measuring an Alberta Stroke Program Early CT (ASPECT) score to assess ischemic changes in stroke -- has secured the CE Mark.












![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






